Plasma concentrations of C-reactive protein and fibrinogen in ischaemic stroke

Journal of International Medical Research

Volumn 30, Issue 6, 2002, Pages 591-596

  Iyigun I ^a   Bakirci, Y ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; C reative protein; Fibrinogen; Inflammation; Ischaemic stroke

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN;

ADULT; AGED; ARTERY LESION; BLOOD SAMPLING; BRAIN ARTERY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMIPARESIS; HEMIPLEGIA; HOSPITAL ADMISSION; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; NERVE INJURY; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; STATISTICAL SIGNIFICANCE; TIME; UNCONSCIOUSNESS;

EID: 0036867361     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000203000607     Document Type: Review

References (27)

1. Kushner I: The phenomenon of the acute phase response. Ann NY Acad Sci 1982; 389: 39 - 48.
2. Coull F, Beamer N, de Garmo P, Sexton G, Nordt F, Knox R, et al: Chronic blood hyperviscosity in subjects with acute stroke, transient ischemic attack, and risk factors for stroke. Stroke 1991; 22: 162 - 168.
3. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501 - 505.
4. Welin L, Svardsudd K, Wilhelmsen L, Larsson B, Tibblin G: Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med 1987; 317: 521 - 526.
5. Beamer NB, Coull BM, Clark WM, Briley DP, Wynn M, Sexton G: Persistent inflammatory response in stroke survivors. Neurology 1998; 50: 1722 - 1728.
6. Resch KL, Ernst E, Matrai A, Paulsen HF: Fibrinogen and viscosity as risk factors for subsequent cardiovascular events in stroke survivors. Ann Intern Med 1992; 117: 371 - 375.
7. Beamer NB, Coull BM, Sexton G, de Garmo P, Knox R, Seaman G: Fibrinogen and the albumin globulin ratio in recurrent stroke. Stroke 1993; 24: 1133-1139.
8. Grau AJ, Buggle F, Becher H, Werle E, Hacke W: The association of leukocyte count, fibrinogen, and C-reactive protein with vascular risk factors and ischemic vascular diseases. Thromb Res 1996; 82: 245 - 255.
9. Grau AJ: Infection, inflammation, and cerebrovascular ischemia. Neurology 1997; 49 (Suppl 4): S47 - S51.
10. Iyigün I, Albayrak A, Yilikoǧlu Y, Parlak Ö, Deǧer O, Aydin IH: The effect of smoking on the serum lipoproteins in patients with cerebral thrombosis. Atatürk Üniversity, Medical Faculty, Medical Bulletin 1986; 18: 505 - 508.
11. Kuller LH, Tracy RP, Shaten J, Meilahn EN: Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996; 144: 537 - 547.
12. Thompson SG, Kienast J, Pyke SDM, Haverkate F, Van de Loo JCW: Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635 - 641.
13. WHO Expert Committee on Biological Standardization: WHO Technical Report Series 760. Geneva: World Health Organization, 1987.
14. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massaro JM, et al: Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: The Framingham Study. Stroke 2001; 32: 2575 - 2579.
15. Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S, et al. for the Cholesterol, And Recurrent Events (CARE) investigators: Inflammation, pravastatin, and the risk of cronary events after myocardial infarction in patients with average cholesterol levels. Circulation 1998; 98: 839 - 844.
16. Lagrand WK, Visser CA, Hermens WT, Niessen HWM, Verheugt FWA, Wolbink GJ, et al: C-reactive protein as a cardiovascular risk factor: more than an epiphenomenona? Circulation 1999; 100: 96 - 102.
17. Di Napoli M, Papa F, Bocola V: C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 2001; 32: 917 - 924.
18. Warlow CP, Dennis MS, Gizn JV: Glasgow outcome scale. In: Stroke. Oxford: Blackwell Science, 1996; p440.
19. Clauss A: Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens (in German). Acta Haematol 1957; 17: 237 - 246.
20. Sternberg JC. A rate nephelometer for measuring specific proteins by immunoprecipitin reactions. Clin Chem 1977; 23: 1456 - 1464.
21. SPSS, 1999: SPSS for Windows Release 10.0, SPSS Inc., Chicago, IL, USA.
22. Wolf PA, Kannel W, D'Agostino RB: Epidemiology of stroke. In: Cerebrovascular Disease: Pathophysiology, Diagnosis, and Management (Ginsberg MD, Bogousslavsky J, eds). Malden, Massachusetts: Blackwell Scientific Publications, Inc, 1998; pp834 - 849.
23. Ross R: Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115 - 126.
24. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448 - 454.
25. Dirnagl U, Iadecola C, Moskowitz MA: Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999; 22: 391 - 397.
26. Tracy RP: Inflammation in cardiovascular disease: cart, horse, or both? Circulation 1998; 97: 2000 - 2002.
27. Kuller LH, Tracy RP: The role of inflammation in cardiovascular disease. Arterioscler Thromb Vasc Biol 2000; 20: 901.